Cargando…
Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination
BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women in the reproductive age group, and is one of the most common causes of hyperandrogenic anovulatory infertility. The aromatase inhibitor, letrozole, has been used for induction of ovulation. The pu...
Autores principales: | Hendawy, Sherif F., Samaha, Hanan E., Elkholy, Mohamed F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888072/ https://www.ncbi.nlm.nih.gov/pubmed/24453507 http://dx.doi.org/10.4137/CMRH.S6598 |
Ejemplares similares
-
Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome
por: Sakar, Mehmet Nafi, et al.
Publicado: (2020) -
Efficacy of letrozole versus clomiphene citrate on ovulation induction in patients with polycystic ovarian syndrome
por: Khakwani, Mehnaz, et al.
Publicado: (2022) -
Comparing of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles
por: Akbari, Soheila, et al.
Publicado: (2012) -
Minimal Stimulation Using Gonadotropin Combined with Clomiphene Citrate or Letrozole for Intrauterine Insemination
por: Yun, Bo Hyon, et al.
Publicado: (2015) -
Clomiphene citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A randomized trial
por: Pourali, Leila, et al.
Publicado: (2017)